ATE470152T1 - Diagnostikverfahren mittels messungen der antiglykan-antikörper-spiegeln - Google Patents

Diagnostikverfahren mittels messungen der antiglykan-antikörper-spiegeln

Info

Publication number
ATE470152T1
ATE470152T1 AT04806548T AT04806548T ATE470152T1 AT E470152 T1 ATE470152 T1 AT E470152T1 AT 04806548 T AT04806548 T AT 04806548T AT 04806548 T AT04806548 T AT 04806548T AT E470152 T1 ATE470152 T1 AT E470152T1
Authority
AT
Austria
Prior art keywords
measurements
diagnostic method
antibodies levels
antiglycan antibodies
antiglycan
Prior art date
Application number
AT04806548T
Other languages
English (en)
Inventor
Nir Dotan
Avinoam Dukler
Original Assignee
Glycominds Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycominds Ltd filed Critical Glycominds Ltd
Priority claimed from PCT/IB2004/004389 external-priority patent/WO2005054853A2/en
Application granted granted Critical
Publication of ATE470152T1 publication Critical patent/ATE470152T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/94—Saccharomyces
    • Y10S435/942—Saccharomyces cerevisiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT04806548T 2003-12-03 2004-12-03 Diagnostikverfahren mittels messungen der antiglykan-antikörper-spiegeln ATE470152T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/728,227 US7592150B2 (en) 2003-12-03 2003-12-03 Method for diagnosing diseases based on levels of anti-glycan antibodies
US10/843,033 US20050142618A1 (en) 2003-12-03 2004-05-11 Method for diagnosing diseases based on levels of anti-glycan antibodies
PCT/IB2004/004389 WO2005054853A2 (en) 2003-12-03 2004-12-03 Method for diagnosing diseases based on levels of anti-glycan antibodies

Publications (1)

Publication Number Publication Date
ATE470152T1 true ATE470152T1 (de) 2010-06-15

Family

ID=34633661

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04806548T ATE470152T1 (de) 2003-12-03 2004-12-03 Diagnostikverfahren mittels messungen der antiglykan-antikörper-spiegeln

Country Status (5)

Country Link
US (3) US7592150B2 (de)
AT (1) ATE470152T1 (de)
DE (1) DE602004027529D1 (de)
ES (1) ES2349804T3 (de)
IL (1) IL175692A0 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004294526A1 (en) * 2003-12-03 2005-06-16 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
US7592150B2 (en) * 2003-12-03 2009-09-22 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
DE102004018418A1 (de) * 2004-04-15 2005-11-10 Euroimmun Medizinische Labordiagnostika Ag Diagnose entzündlicher Darmerkrankungen, insbesondere Colitis ulcerosa
CA2571431A1 (en) * 2004-06-24 2006-01-05 The Scripps Research Institute Arrays with cleavable linkers
EP1957982A2 (de) * 2005-12-05 2008-08-20 Guava Technologies, Inc. Charakterisierung von analyten auf teilchenbasis
WO2009069007A2 (en) * 2007-11-30 2009-06-04 Glycominds, Ltd. Composition and method for prediction of complicated disease course and surgeries in crohn's disease
CA2794757A1 (en) * 2008-11-11 2010-05-20 Prometheus Laboratories Inc. Methods for prediction of inflammatory bowel disease (ibd) using serologic markers
CN101403749B (zh) * 2008-11-17 2012-11-07 北京大学 通过葡聚糖特异性抗体辅助诊断自身免疫性疾病的试剂盒
CN104007102A (zh) * 2013-02-21 2014-08-27 林斯 板式化学发光免疫诊断试剂通用固相包被板及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292667A (en) 1988-06-29 1994-03-08 The General Hospital Corporation Detection and treatment of ulcerative colitis
AU2484892A (en) * 1991-08-09 1993-03-02 Washington University Autoantibodies and their targets in the diagnosis of peripheral neuropathies
US6074835A (en) * 1996-04-12 2000-06-13 Regents Of The Univ. Of California Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1
US6033864A (en) * 1996-04-12 2000-03-07 The Regents Of The University Of California Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
US5932429A (en) * 1996-04-12 1999-08-03 Cedars-Sinai Medical Center Methods of diagnosing clinical subtypes of crohn's disease
US6084092A (en) * 1997-01-31 2000-07-04 The Collaborative Group, Ltd. β(1-3)-glucan diagnostic assays
US6218129B1 (en) * 1998-05-15 2001-04-17 Prometheus Laboratories, Inc. Inflammatory bowel disease first step assay system
EP1785726A1 (de) 1999-02-17 2007-05-16 Carbozyme NT Ltd Kombinatorische Bibliotheken komplexer Kohlenhydrate und Verfahren zu ihrer Herstellung und Verwendung
US6994966B2 (en) 2000-02-17 2006-02-07 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
FR2802536B1 (fr) * 1999-11-23 2003-06-13 Chru Lille Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections
AU1861001A (en) 1999-11-29 2001-06-12 Syntesome Gesellschaft Fur Medizinische Biochemie Mbh Arrays of glycan molecules (glycoarrays) on the surface of biochips (glycochips)and uses thereof
US6872540B2 (en) 2001-10-26 2005-03-29 Techlab, Inc. Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae
EP1529216B1 (de) 2002-08-02 2007-10-24 Glycominds Ltd. Verfahren zur diagnose von multipler sklerose
US20040053263A1 (en) * 2002-08-30 2004-03-18 Abreu Maria T. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
US7592150B2 (en) * 2003-12-03 2009-09-22 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
AU2004294526A1 (en) * 2003-12-03 2005-06-16 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
US20060205022A1 (en) * 2003-12-03 2006-09-14 Nir Dotan Method for diagnosing and prognosing inflammatory bowel disease and crohn's disease

Also Published As

Publication number Publication date
US7592150B2 (en) 2009-09-22
US20100099124A1 (en) 2010-04-22
US20050142618A1 (en) 2005-06-30
DE602004027529D1 (de) 2010-07-15
IL175692A0 (en) 2008-02-09
ES2349804T3 (es) 2011-01-11
US20050124006A1 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
WO2005054853A3 (en) Method for diagnosing diseases based on levels of anti-glycan antibodies
NO339224B1 (no) Bedrede immunprøvemetoder
PT1506406E (pt) Diagnóstico de carcinoma hepatocelular
IL193426A0 (en) Methods for the diagnosis of dementia and other neurological disorders
CY1107859T1 (el) Μεθοδος για διαγνωση πολλαπλης σκληρυνσης
EP2185931A4 (de) Verwendung von secretor-, lewis- und sialyl-antigen-konzentrationen als krankheitsvorhersage-indikatoren
ATE491953T1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
Wong et al. Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe
IN2015DN03125A (de)
WO2005104806A3 (en) Noninvasive analyzer sample probe interface method and apparatus
EP1996940A4 (de) Nachweis von krebs anhand von erhöhten bcl-2-konzentrationen
WO2006073682A3 (en) Diagnostic test
EA200500356A1 (ru) Способы обнаружения амниотической жидкости во влагалищном секрете и устройства для реализации указанных способов
WO2006052765A3 (en) Cycle and load measurement device
WO2009001545A1 (ja) 移植片対宿主疾患の検査および治療方法
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
NO20050186L (no) Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
ATE470152T1 (de) Diagnostikverfahren mittels messungen der antiglykan-antikörper-spiegeln
EP1476757A4 (de) Verfahren und kit zur krebsvorhersage
DE60112949D1 (de) Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
DE60133997D1 (de) Verfahren zum vorhersagen von preeclampsia und anderen krankheiten
DE602004013355D1 (de) Verwendung des proteins spee als marker für brustkrebs
NZ590993A (en) Dual specificity phosphatase 1 protein (DUSP1) for diagnosis and prognosis of skin cancer
ATE511646T1 (de) Diagnose mykobakterieller infektionen mittels bestimmung von ifn-gamma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties